Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.5200
+0.0100 (1.96%)
Aug 28, 2026, 3:06 PM EST
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 39.41 million as of August 28, 2026. Its market cap has decreased by -1.35% in one year.
Market Cap
39.41M
Enterprise Value
38.02M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.52
ChartMarket Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 39.41M, a decrease of -55.76%. That is a compound annual growth rate of -14.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 39.41M | -4.59% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BriaCell Therapeutics | 45.15M |
| Medicenna Therapeutics | 43.84M |
| Microbix Biosystems | 43.83M |
| Sernova Biotherapeutics | 41.54M |
| Sona Nanotech | 41.14M |
| Telescope Innovations | 39.20M |
| The More Life Company | 36.56M |
| Thiogenesis Therapeutics | 35.69M |